PRM11 Real-World Data to Calculate Cost-Effectiveness of Monoclonal Antibodies- Problems and Solutions
Abstract
Authors
E.M. van Rooijen N. van der Linden C. van Gils M. Oppe C. Uyl-de Groot
E.M. van Rooijen N. van der Linden C. van Gils M. Oppe C. Uyl-de Groot
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now